Galectin Therapeutics Inc... (GALT)
undefined
undefined%
At close: undefined
2.20
4.51%
Pre-market Dec 16, 2024, 08:48 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00
Net Income -41.07M -38.78M -30.53M -23.46M -13.29M -13.90M -16.23M -21.44M -20.03M -15.79M -12.09M -9.68M -10.91M -5.63M -7.46M -3.15M -9.43M -3.19M -6.54M -7.18M -4.87M -3.68M -3.97M -190.00K
Depreciation & Amortization 33.00K 32.00K 41.00K 36.00K 35.00K - 1K 7.00K 7.00K 10.00K 12.00K 9.00K 9.00K 12.00K 37.00K 49.00K 64.00K 67.00K 81.00K 81.00K 89.17K 211.18K 159.47K -
Stock-Based Compensation 2.26M 2.87M 2.08M 1.80M 1.68M 4.45M 1.10M 2.48M 3.40M 4.07M 3.79M 2.79M 3.25M 1.94M 1.61M 697.00K 616.00K 416.00K 23.00K 162.00K 618.87K 147.32K - -
Other Working Capital 2.01M 724.00K 65.00K -1.59M -356.00K 19.00K 8.00K 122.00K 420.00K -335.00K 1.38M -626.00K 188.00K -543.00K 274.00K -237.00K 73.00K 122.00K -81.00K -32.00K -15.70K -24.09K 160.12K 80.00K
Other Non-Cash Items 1.13M -147.00K 489.00K 87.00K 87.00K 348.00K 45.00K 2.48M 3.40M 4.07M 3.79M 2.79M -10.39M 1.26M 1.53M -2.13M 3.70M -3.23M 43.00K 171.00K 618.87K 351.59K 1.85M 20.00K
Deferred Income Tax - - -138.00K - - - - -2.48M -3.40M -3.67M -3.79M -2.79M 10.91M - - - -616.00K -416.00K -23.00K -162.00K -618.87K -147.32K - -
Change in Working Capital 4.68M 4.97M 3.75M 942.00K 641.00K -1.07M -804.00K 2.54M -363.00K -1.12M 803.00K -626.00K 1.46M -683.00K 399.00K -126.00K 184.00K -406.00K 293.00K 595.00K 12.93K 133.00K 160.12K 80.00K
Operating Cash Flow -32.97M -31.06M -24.31M -20.60M -10.85M -10.18M -15.89M -16.41M -16.98M -12.43M -7.48M -7.50M -5.68M -3.10M -3.89M -4.67M -5.48M -6.76M -6.13M -6.33M -4.15M -2.98M -1.80M -90.00K
Capital Expenditures - - - - - - - - - - -5.00K -5.00K -5.00K - - -2.00K -42.00K -98.00K -21.00K -23.00K -39.36K -109.30K -171.12K -10.00K
Acquisitions - - - - - - - - - -400.00K - - - - - - - - - - - - - -
Purchase of Investments - - - - - - - - - -400.00K - - - - - - - -5.00M - - - - - -
Sales Maturities Of Investments - - - - - - - - - - - - - - - - 5.00M - - - - - - -
Other Investing Acitivies - - - - - - - - -400.00K 400.00K 69.00K 69.00K -10.00K - - 11.00K -11.00K -138.00K -90.00K -46.00K -66.34K -28.98K - -
Investing Cash Flow - - - - - - - - -400.00K -400.00K 64.00K 64.00K -15.00K - - 9.00K 4.95M -5.24M -111.00K -69.00K -105.70K -138.28K -171.12K -10.00K
Debt Repayment 30.00M 10.00M 30.00M - - - - - - - - - - - - - -555.00K 8.30M - - - -86.00K - -
Common Stock Repurchased 671.00K 899.00K - - - - - - - - - - - - -1.34M - - - - - - - - 10.00K
Dividend Paid - -97.00K -171.00K -137.00K -394.00K -915.00K -1.23M -741.00K -943.00K -943.00K -976.00K - -1.54M -2.07M -209.00K - - - - - - - - -
Other Financial Acitivies 10.03M 97.00K 171.00K 137.00K - 915.00K 1.23M 741.00K 868.00K 3.07M 5.75M - 7.73M 10.81M 4.03M 254.00K 1.64M - - - 442.00 - 1.04M 300.00K
Financial Cash Flow 40.03M 10.00M 36.81M 263.00K 50.08M 15.38M 3.58M 5.92M 13.70M 31.46M 8.61M 10.40M 6.20M 8.74M 3.82M 3.65M 1.08M 8.30M - 9.50M 9.94M 3.55M 3.26M 300.00K
Net Cash Flow 7.07M -21.06M 12.51M -20.34M 39.23M 5.20M -12.31M -10.48M -3.28M 18.64M 1.13M 2.97M 506.00K 5.64M -67.00K -1.00M 546.00K -3.69M -6.24M 3.10M 5.69M 430.06K 1.29M 210.00K
Free Cash Flow -32.97M -31.06M -24.31M -20.60M -10.85M -10.18M -15.89M -16.41M -16.98M -12.43M -7.49M -7.50M -5.68M -3.10M -3.89M -4.67M -5.53M -6.86M -6.15M -6.36M -4.19M -3.09M -1.97M -100.00K